Skip to main content

Table 2 Patient and clinical characteristics of ICC group

From: Dynamic 18F-FDG PET imaging of liver lesions: evaluation of a two-tissue compartment model with dual blood input function

Patient number

Gender

Age

Previous treatment

Lesion number

Lesion size (cm3)

Lesion SUVmax

1

M

36

RFA, ICI

3

0.74

9.24

     

0.86

14.81

     

0.51

17.43

2

M

42

Surgery

3

1.11

7.80

     

2.40

9.94

     

1.25

11.57

3

M

70

Surgery, radiotherapy, chemotherapy, gamma knife radiotherapy, ICI

1

2.95

5.10

4

M

61

ICI

1

106.97

12.05

5

M

47

Surgery, chemotherapy, RFA, ICI

3

1.82

4.49

     

5.29

2.95

     

82.40

5.26

6

F

73

Radiotherapy, chemotherapy, gamma knife radiotherapy, RFA, ICI

1

2.79

7.67

7

M

49

Surgery, chemotherapy, ICI

2

5.01

4.30

     

15.85

5.01

8

M

52

Surgery, TACE, RFA, ICI

1

2.71

4.78

9

M

74

ICI

1

27.08

5.42

10

F

44

Surgery, chemotherapy, RFA, ICI

1

6.95

8.93

11

F

54

Surgery, chemotherapy

1

0.92

4.64

12

M

62

Surgery, chemotherapy, ICI

2

6.04

7.97

     

5.22

6.83

13

M

55

TACE, chemotherapy, ICI

1

29.35

11.19

14

M

74

Surgery, TACE, ICI

2

8.72

4.22

     

2.82

4.41

15

F

56

Surgery, chemotherapy, TACE, RFA

2

4.08

5.04

     

4.80

5.97

Mean ± SD

 

56.60 ± 12.19

  

13.15 ± 25.89

7.48 ± 3.65

  1. TACE = transcatheter arterial chemoembolization; RFA = Radio Frequency Ablation, ICI = immune checkpoint inhibitor